PT Royal Medicalink Pharmalab
Vipilac®
Packaging Specifications

Box, 3 Blisters @ 10 Capsules (Total 30 Capsules)

Official BPOM License

POM SD211317581

ProbioticsMedical SupplementPT Royal Medicalink Pharmalab

Vipilac®

Indigenous Indonesian Probiotic Innovation for Gastrointestinal Health

Product Overview

Vipilac® is a clinical synbiotic breakthrough combining indigenous Indonesian probiotic strains (Lactobacillus plantarum Dad-13 and Bifidobacterium) isolated from healthy Indonesian populations. Specifically formulated for high tolerance against gastric acid and bile salts, Vipilac® reaches the intestine alive to recolonize the gut microbiota, suppress pathogenic bacteria, and optimize nutrient absorption.

Key Health Benefits & Therapeutic Indications

Key Therapeutic Benefits:
- Maintains gastrointestinal microflora balance and strengthens intestinal mucosal immunity.
- Alleviates dyspepsia, bloating, diarrhea, constipation, and Irritable Bowel Syndrome (IBS).
- Restores gut microbiota after prolonged antibiotic therapy.
- Strengthens gut barrier integrity to prevent bacterial endotoxin translocation.

Detailed Composition & Active Ingredients

Active Ingredients per Capsule:
- Standardized Lactobacillus plantarum Dad-13: > 1 x 10⁹ CFU
- Bifidobacterium animalis subsp. lactis: > 1 x 10⁹ CFU
- Natural Fructooligosaccharides (Prebiotic FOS): 100 mg
- High-grade Pharmaceutical Excipients q.s. 500 mg

Dosage & Administration Guidelines

Adults: 1 - 2 capsules daily, taken before or after meals.
Post-Antibiotic Recovery: 2 capsules daily for 14 consecutive days.
Children above 6 years: 1 capsule daily or as directed by physician.

Clinical Research & Quality Assurance

Validated through in-vitro and multicenter clinical trials by the Center for Food and Nutrition Studies UGM and National Referral Hospitals, demonstrating over 90% intestinal viability and proven enhancement of mucosal sIgA levels.